November 12, 2025 — Leads & Copy —
Claritev Corporation (NYSE: CTEV) has announced the commencement of an underwritten public offering of 1,500,000 shares of its Class A common stock by certain affiliates of Hellman & Friedman, the selling stockholders.
The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 225,000 shares of Class A common stock. The underwriters plan to offer these shares to the public at a fixed price, which is subject to change without notice.
Claritev will not sell any shares in the offering and will not receive any proceeds from the sale of shares by the selling stockholders.
The offering is subject to market and other conditions, and its completion is not assured.
Barclays, Guggenheim Securities, and Wells Fargo Securities are the joint-lead bookrunning managers for the offering. Citigroup and Piper Sandler are serving as additional bookrunners.
The offering will be made through a prospectus supplement and accompanying prospectus filed with the Securities and Exchange Commission (SEC). These documents will be available on the SEC’s website.
Before investing, investors should read the prospectus supplement, the accompanying prospectus, and other documents filed with the SEC for detailed information about Claritev and the offering. These documents are available for free on the SEC’s website at www.sec.gov.
Barclays Capital Inc., Guggenheim Securities, LLC, or Wells Fargo Securities, LLC can provide the prospectus supplement and accompanying prospectus relating to the offering. Contact information is as follows:
Barclays Capital Inc.: c/o Broadridge Financial Solutions, 1155 Long Island Avenue Edgewood, NY 11717, telephone at (888) 603-5847, or email at Barclaysprospectus@broadridge.com.
Guggenheim Securities, LLC: 330 Madison Avenue, 8th Floor, New York, NY 10017, Attention: Equity Syndicate Department, telephone at (212) 518-9544, or email at GSEquityProspectusDelivery@guggenheimpartners.com.
Wells Fargo Securities, LLC: 90 South 7th Street, 5th Floor, Minneapolis, MN 55402, Attention: Wells Fargo Securities, telephone at (800) 645-3751 (option #5) or email at WFScustomerservice@wellsfargo.com.
This press release does not constitute an offer to sell or a solicitation to buy securities, nor will there be any sale of securities in any jurisdiction where such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. Any offers, solicitations, or sales of securities will be made according to the Securities Act of 1933.
Claritev is focused on improving affordability, transparency and quality in healthcare. The company provides tech-enabled solutions and services using data and AI solutions to power an enterprise platform delivering meaningful insights to drive affordability in healthcare, bring price transparency and optimizes networks and benefits design.
Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers.
This release contains forward-looking statements that involve risks and uncertainties, and actual results may differ materially from those projected. The company does not undertake any obligation to update or revise any forward-looking statements.
Source: Claritev Corporation
